Name: Latest research reports of Alkem Laboratories Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Alkem Laboratories Ltd.
Rating: 1
Author: BOB Capital Markets Ltd.

Alkem Laboratories Ltd.

NSE: ALKEM | BSE: 539523 | ISIN: INE540L01014 | Industry: Pharmaceuticals
| Mid-range Performer

4953.3000 -4.30 (-0.09%)

NSE Apr 17, 2025 15:31 PM

Volume: 45,830

Alkem Laboratories Ltd.

20 May 2023

4953.30

-0.09%

Alkem Labs (SELL): Margin improvement key for revival

Sell: Alkem Laboratories Ltd.

BOB Capital Markets Ltd.

Q4 EBITDA/PAT of Rs 3.5bn/Rs 710mn well short of consensus by 21%/ 79% primarily due to higher operating costs

Number of FII/FPI investors increased from 524 to 535 in Mar 2025 qtr.